Skip to search formSkip to main contentSkip to account menu

BMS-182751

National Institutes of Health

Related topics

Related topics

2 relations
JM 216

Broader (1)

satraplatin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
Oral Chemotherapy in Head and Neck Cancer
Chemotherapy plays an important role in the palliative treatment of head and neck cancer and in the neoadjuvant setting for… 
2002
2002
A phase II trial of JM-216 in cervical cancer: an NCIC CTG study.
OBJECTIVE BMS-182751 (JM-216) is an orally bioavailable platinum compound with activity in platinum-sensitive and platinum… 
1999
1999
Rectal absorption of [Bis (acetato) ammine dichloro (cyclohexylamine) platinum(IV)] (BMS-182751), a new anti-tumor agent, in rats.
The rectal absorption of a platinum anti-tumor agent, [bis (acetato) ammine dichloro (cyclohexylamine) platinum(IV)] (BMS-182751… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)